Hi, I'm Brent. My work sits at the intersection of chromatin biology, cell signaling, and computation. I'm a PhD candidate at the Salk Institute in Diana Hargreaves' lab, where I study how BAF (mSWI/SNF) chromatin remodeling complexes interpret cellular signals to control cell fate.
Fascinated by chromatin's ability to buffer noise and encode memory, I aim to understand and leverage these properties to develop new approaches to cell engineering and therapeutic design. My research has been published in Nature, Nature Methods, Cell Stem Cell, Cell Reports, The Journal of Immunology, and others, with first-author research papers in Immunity and the Yale Journal of Biology and Medicine, and invited commentary in Nature Genetics and Nature Structural & Molecular Biology.
Before Salk, I did my MA at UCSB with Max Wilson, using optogenetic tools to interrogate signaling dynamics. Earlier, I worked with Gay Crooks and Chris Seet at UCLA on stem cell-derived T cell development, contributing to the Nature Methods paper describing artificial thymic organoids and follow-up work in Cell Stem Cell and Cell Reports. I started in research as an undergraduate at UCSD in Stephen Hedrick's lab.
I'm joining industry in 2027 with a focus on epigenetic engineering, cell therapy, and AI×bio companies in the Bay Area. If you're working on hard, interesting problems in any of those areas, I'd love to get in touch.
Research
I work on how cells use chromatin to encode, stabilize, and rewire identity, and how to leverage those mechanisms to understand and engineer cell behavior. My approach pairs wet-lab genomics and bioengineering with computational analysis.
01Chromatin remodeling and T cell fate
My PhD work focuses on the BAF (mSWI/SNF) chromatin remodeling complex in T cells. In a 2023 Immunity paper (co-first author), we showed that canonical BAF activity shapes the enhancer landscape that licenses CD8⁺ T cell effector and memory fates. Loss of BAF function blocks the chromatin priming required for memory commitment, implicating BAF as a key regulator of T cell durability with direct relevance to next-generation cell therapies.
02Dynamic signaling and chromatin
The final chapter of my PhD is focused on how chromatin decodes dynamic signaling. Most chromatin profiling treats signaling as a static input, but cells in vivo encounter signals that vary in amplitude, duration, and timing. To get at this, I pair optogenetic control of signaling pathways with a simplified 96-well CUT&RUN protocol I built, mapping how time-varying inputs translate into changes in chromatin state and gene regulation.
03In vitro T cell engineering from stem cells
Earlier in the Crooks lab at UCLA, I contributed to the development of the artificial thymic organoid (ATO) system, a stromal cell-based platform for generating mature T cells from human hematopoietic stem cells in vitro. The original methodology (Nature Methods, 2017) and extensions in Cell Stem Cell (2019) and Cell Reports (2020) gave the field a tractable system to dissect human T cell development and to generate engineered T cells from iPSCs.
04Bioengineering and signaling dynamics
My MA work at UCSB with Max Wilson used optogenetic tools to perturb signaling pathways with quantitative control over timing and amplitude. The bioengineering perspective of that lab still shapes how I think about chromatin and cell-state transitions: dynamics, feedback, and hysteresis, rather than static localization.
05What I'm thinking about next
Where I want to push next is the intersection of chromatin biology and modern ML, with an eye toward therapeutic applications of chromatin engineering. More on this to come.
Publications
Selected publications. Full list on Google Scholar.
-
Mechanisms and consequences of nucleosome remodeling by mammalian SWI/SNF complexes
-
Atlas-guided discovery of transcription factors for T cell programming
-
The antiviral interferon pathway drives astrocyte aging and motor decline
-
RNA polymerase II promoter-proximal pausing promotes BAF chromatin binding and remodeling
-
Early chromatin remodeling events in acutely stimulated CD8⁺ T cells
-
Switching under selection: how CoREST controls endocrine therapy resistance in ER+ breast cancer
-
In vitro recapitulation of murine thymopoiesis from single hematopoietic stem cells
-
Pleiotropic roles of VEGF in the microenvironment of the developing thymus
-
Organoid-induced differentiation of conventional T cells from human pluripotent stem cells
Code
More on GitHub